Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
information for practice,
Options for opioid agonist therapy (OAT) are expanding with the development of prolonged-release (also known as extended-release…